Risk-based Monitoring jargon doesn’t require rocket science. You don’t have to be a statistician to analyse and interpret KPIs, KRIs and KQIs. We explain their meaning and differences through simple examples, so you can optimise key performance of your clinical trials.
What feeling do you have, when starting a new clinical trial? Do you hope all past problems will stay in the past and that everything will be better from now on? Does it surprise you that the skill set of project managers seems to be a critical source of error according to industry experts? Then continue reading...
Electronic Data capturing is developing already for more than 30 years and penetrating the clinical research more and more. Already more than half of all clinical trials are conducted purely electronically, although the process is not yet complete. Recently did the FDA underlined its [...]
At Cyntegrity we're developing a system for risk-based monitoring (RBM) of clinical trials. Even though one could argue that risk-based processes are under-represented in crucial areas of a clinical trial, the idea in general of course is not new. Risk-based approaches are well established in [...]
